News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Clinuvel reveals study results, and Cann’s Mildura cannabis facility is a go
Health & Biotech
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks
Experts
ScoPo’s Powerplays: Who’s staying afloat in the inflation storm?
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Mesoblast and the ASX’s other big biotechs have intrigued investors this year; here’s what’s in store next
Health & Biotech
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
Health & Biotech
ASX Health Stocks: Acrux flags testosterone solution with an armpit application, Clinuvel posts record revenues
Director Trades
Directors Trades: It’s a new financial year, so who’s hoping for better returns and who’s selling to pay a tax bill?
Health & Biotech
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare
Health & Biotech
‘Miracle’ breakthrough in melanoma fight puts focus on ASX stocks in the skin cancer space
Director Trades
Directors’ Trades: Who bought their company’s ASX shares on market just 2 days post-IPO?
Health & Biotech
Clinuvel to study using Scenesse implant to help ‘moon children’
News
Afterpay just joined the top 20 ASX stocks; how many others were once small caps?
Experts
ScoPo’s health powerplays: ‘We said October was going to be volatile’
News